JP2023534232A5 - - Google Patents

Info

Publication number
JP2023534232A5
JP2023534232A5 JP2023501772A JP2023501772A JP2023534232A5 JP 2023534232 A5 JP2023534232 A5 JP 2023534232A5 JP 2023501772 A JP2023501772 A JP 2023501772A JP 2023501772 A JP2023501772 A JP 2023501772A JP 2023534232 A5 JP2023534232 A5 JP 2023534232A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023501772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/041487 external-priority patent/WO2022015766A1/en
Publication of JP2023534232A publication Critical patent/JP2023534232A/ja
Publication of JP2023534232A5 publication Critical patent/JP2023534232A5/ja
Pending legal-status Critical Current

Links

JP2023501772A 2020-07-13 2021-07-13 免疫原性構築物、組成物、および免疫応答を誘導する方法 Pending JP2023534232A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063051351P 2020-07-13 2020-07-13
US63/051,351 2020-07-13
PCT/US2021/041487 WO2022015766A1 (en) 2020-07-13 2021-07-13 Immunogenic constructs, compositions, and methods for inducing immune response

Publications (2)

Publication Number Publication Date
JP2023534232A JP2023534232A (ja) 2023-08-08
JP2023534232A5 true JP2023534232A5 (enExample) 2025-04-15

Family

ID=79554246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023501772A Pending JP2023534232A (ja) 2020-07-13 2021-07-13 免疫原性構築物、組成物、および免疫応答を誘導する方法

Country Status (9)

Country Link
US (3) US20230233668A1 (enExample)
EP (1) EP4178627A1 (enExample)
JP (1) JP2023534232A (enExample)
KR (1) KR20230040345A (enExample)
CN (1) CN116234587A (enExample)
AU (1) AU2021307416A1 (enExample)
CA (1) CA3182756A1 (enExample)
MX (1) MX2023000663A (enExample)
WO (1) WO2022015766A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023159082A2 (en) * 2022-02-15 2023-08-24 Ohio State Innovation Foundation Nanotechnology based intranasal vaccine for covid-19 comprising chitosan
CN116694568A (zh) * 2022-03-02 2023-09-05 北京市希波生物医学技术有限责任公司 用于激活整体抗肿瘤免疫系统的培养基配方物及制备激动剂激活的整体免疫效应细胞的方法
KR20260007445A (ko) * 2024-07-05 2026-01-14 한국과학기술원 핵산 전달용 다중층 나노입자
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2798739A1 (en) * 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
EP3046547A4 (en) * 2013-09-18 2017-05-24 Stc.Unm Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo
CN103627005B (zh) * 2013-11-08 2016-07-06 上海交通大学 聚乙二醇修饰的聚乙烯亚胺及其作为抗原蛋白载体的用途
WO2015077657A2 (en) * 2013-11-22 2015-05-28 City Of Hope Stat3 inhibitors and uses thereof
CA2933910A1 (en) * 2013-12-19 2015-06-25 The University Of Queensland Method of synthesis of silica vesicles and use thereof
EP4480902A3 (en) * 2015-03-16 2025-03-12 PDX Pharmaceuticals, Inc. Cross-linked polymer modified nanoparticles
AU2016341309A1 (en) * 2015-10-22 2018-06-07 Modernatx, Inc. Cancer vaccines
WO2018065623A2 (en) * 2016-10-07 2018-04-12 Enterome Immunogenic compounds for cancer therapy
WO2020014644A1 (en) * 2018-07-12 2020-01-16 The Regents Of The University Of Michigan Compositions and methods for metal containing formulations capable of modulating immune response
CN109847057A (zh) * 2018-12-28 2019-06-07 上海交通大学 一种三元复合物及其制备方法和应用
US20220249389A1 (en) * 2019-07-12 2022-08-11 Oregon Health & Science University Immunotherapeutic constructs and methods of their use

Similar Documents

Publication Publication Date Title
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2021169491A5 (enExample)
JP2022068302A5 (enExample)
JP2021028398A5 (enExample)
JP2023116721A5 (enExample)
JP2021038271A5 (enExample)
JP2024023385A5 (enExample)
JP2023022224A5 (enExample)
JP2020042034A5 (enExample)
JP2020127428A5 (enExample)
JP2022523200A5 (enExample)
JP2024016014A5 (enExample)
JP2021518389A5 (enExample)
JP2023100643A5 (enExample)
JP2022060295A5 (enExample)
JP2025506484A5 (enExample)
JP2022537813A5 (enExample)
JP2020171301A5 (enExample)
JP2020120660A5 (enExample)
JP2021524864A5 (enExample)
JP2022022379A5 (enExample)
JP2023085551A5 (enExample)
JP2024534771A5 (enExample)